Acadia Pharma (ACAD) Misses Q1 EPS by 6c
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $29.50 +1.58%
Financial Fact:
Collaborative revenues: 5.27M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Collaborative revenues: 5.27M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.27), $0.06 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $118.46 million versus the consensus estimate of $119.99 million.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
- S&P 500 may pull back before midterms, but Citi says buy the dip
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
